Search research articles
Contact Us
Filters
Showing results (91-100 of 100) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 100 results.
Molecular Cancer
|
February 21, 2024
The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma
Valentin Feichtenschlager, Linan Chen, Yixuan James Zheng, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 7, 2025
Switching PD-1 to BRAF + MEK inhibition improves recurrence-free survival in patients receiving a second course of adjuvant melanoma therapy
Katharina Schumann, Kai Christian Klespe, Cornelia Mauch, et al.
Research Square
|
December 11, 2023
The therapeutically actionable long non-coding RNA '<i>T-RECS</i>' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma
Valentin Feichtenschlager, Linan Chen, Yixuan James Zheng, et al.
The British Journal of Dermatology
|
October 12, 2025
Real-world evidence on palmoplantar pustulosis: patient characteristics, diagnostic challenges and predictive factors for treatment survival - a retrospective registry study
Thomas Graier, Natalie Bordag, Wolfgang Weger, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 14, 2022
Adult-Onset Neurodegeneration in Nucleotide Excision Repair Disorders (NERD<sub>ND</sub> ): Time to Move Beyond the Skin
Isabell Cordts, Demet Önder, Andreas Traschütz, et al.
Journal for Immunotherapy of Cancer
|
March 30, 2020
Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients
Teresa Amaral, Felix Kiecker, Sarah Schaefer, et al.
Journal for Immunotherapy of Cancer
|
January 20, 2021
Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
Aljosja Rogiers, Ines Pires da Silva, Chiara Tentori, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 26, 2022
Real-world outcomes using PD-1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland
Katharina Schumann, Cornelia Mauch, Kai-Christian Klespe, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 15, 2025
Addiction and chronic skin diseases: A Pan-European study on prevalence, associations and patient impact
Stefanie Ziehfreund, Magdalena Saak, Alisa Schaal, et al.
Journal of Cancer Research and Clinical Oncology
|
November 21, 2020
Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG)
Theresa Steeb, Anja Wessely, Mareike Alter, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 100) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 100 results.
Molecular Cancer
|
February 21, 2024
The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma
Valentin Feichtenschlager, Linan Chen, Yixuan James Zheng, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 7, 2025
Switching PD-1 to BRAF + MEK inhibition improves recurrence-free survival in patients receiving a second course of adjuvant melanoma therapy
Katharina Schumann, Kai Christian Klespe, Cornelia Mauch, et al.
Research Square
|
December 11, 2023
The therapeutically actionable long non-coding RNA '<i>T-RECS</i>' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma
Valentin Feichtenschlager, Linan Chen, Yixuan James Zheng, et al.
The British Journal of Dermatology
|
October 12, 2025
Real-world evidence on palmoplantar pustulosis: patient characteristics, diagnostic challenges and predictive factors for treatment survival - a retrospective registry study
Thomas Graier, Natalie Bordag, Wolfgang Weger, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 14, 2022
Adult-Onset Neurodegeneration in Nucleotide Excision Repair Disorders (NERD<sub>ND</sub> ): Time to Move Beyond the Skin
Isabell Cordts, Demet Önder, Andreas Traschütz, et al.
Journal for Immunotherapy of Cancer
|
March 30, 2020
Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients
Teresa Amaral, Felix Kiecker, Sarah Schaefer, et al.
Journal for Immunotherapy of Cancer
|
January 20, 2021
Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
Aljosja Rogiers, Ines Pires da Silva, Chiara Tentori, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 26, 2022
Real-world outcomes using PD-1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland
Katharina Schumann, Cornelia Mauch, Kai-Christian Klespe, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 15, 2025
Addiction and chronic skin diseases: A Pan-European study on prevalence, associations and patient impact
Stefanie Ziehfreund, Magdalena Saak, Alisa Schaal, et al.
Journal of Cancer Research and Clinical Oncology
|
November 21, 2020
Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG)
Theresa Steeb, Anja Wessely, Mareike Alter, et al.
Page
of 10